290 related articles for article (PubMed ID: 27995408)
1. High Expression of BCCIP β Can Promote Proliferation of Esophageal Squamous Cell Carcinoma.
Chen L; Ni S; Li M; Shen C; Lin Z; Ouyang Y; Xia F; Liang L; Jiang W; Ni R; Zhang J
Dig Dis Sci; 2017 Feb; 62(2):387-395. PubMed ID: 27995408
[TBL] [Abstract][Full Text] [Related]
2. PKC iota promotes cellular proliferation by accelerated G1/S transition via interaction with CDK7 in esophageal squamous cell carcinoma.
Ni S; Chen L; Li M; Zhao W; Shan X; Wu M; Cheng J; Liang L; Wang Y; Jiang W; Zhang J; Ni R
Tumour Biol; 2016 Oct; 37(10):13799-13809. PubMed ID: 27481515
[TBL] [Abstract][Full Text] [Related]
3. Sam68 promotes cellular proliferation and predicts poor prognosis in esophageal squamous cell carcinoma.
Wang Y; Liang L; Zhang J; Li M; Zhu J; Gong C; Yang L; Zhu J; Chen L; Ni R
Tumour Biol; 2015 Nov; 36(11):8735-45. PubMed ID: 26050229
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of DDX46 inhibits proliferation and induces apoptosis in esophageal squamous cell carcinoma cells.
Li B; Li YM; He WT; Chen H; Zhu HW; Liu T; Zhang JH; Song TN; Zhou YL
Oncol Rep; 2016 Jul; 36(1):223-30. PubMed ID: 27176873
[TBL] [Abstract][Full Text] [Related]
5. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma.
Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of SALL4 reduces tumorigenicity involving epithelial-mesenchymal transition via Wnt/β-catenin pathway in esophageal squamous cell carcinoma.
He J; Zhou M; Chen X; Yue D; Yang L; Qin G; Zhang Z; Gao Q; Wang D; Zhang C; Huang L; Wang L; Zhang B; Yu J; Zhang Y
J Exp Clin Cancer Res; 2016 Jun; 35(1):98. PubMed ID: 27329034
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of Dishevelled-2 contributes to proliferation and migration of human esophageal squamous cell carcinoma.
Zhou G; Ye J; Sun L; Zhang Z; Feng J
J Mol Histol; 2016 Jun; 47(3):287-95. PubMed ID: 27083564
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA, tissue differentiation-inducing nonprotein coding RNA is upregulated and promotes development of esophageal squamous cell carcinoma.
Xu Y; Qiu M; Chen Y; Wang J; Xia W; Mao Q; Yang L; Li M; Jiang F; Xu L; Yin R
Dis Esophagus; 2016 Nov; 29(8):950-958. PubMed ID: 26833746
[TBL] [Abstract][Full Text] [Related]
9. Poly (C)-binding protein 2 (PCBP2) promotes the progression of esophageal squamous cell carcinoma (ESCC) through regulating cellular proliferation and apoptosis.
Ye J; Zhou G; Zhang Z; Sun L; He X; Zhou J
Pathol Res Pract; 2016 Aug; 212(8):717-25. PubMed ID: 27461833
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of HO-1 expression, cellular ROS production, cellular proliferation and cellular apoptosis in human esophageal squamous cell carcinoma tumors and cell lines.
Ren QG; Yang SL; Hu JL; Li PD; Chen YS; Wang QS
Oncol Rep; 2016 Apr; 35(4):2270-6. PubMed ID: 26780849
[TBL] [Abstract][Full Text] [Related]
11. High expression of TACC3 in esophageal squamous cell carcinoma correlates with poor prognosis.
Huang ZL; Lin ZR; Xiao YR; Cao X; Zhu LC; Zeng MS; Zhong Q; Wen ZS
Oncotarget; 2015 Mar; 6(9):6850-61. PubMed ID: 25760075
[TBL] [Abstract][Full Text] [Related]
12. High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation.
Wang C; Li Z; Shao F; Yang X; Feng X; Shi S; Gao Y; He J
J Exp Clin Cancer Res; 2017 Jun; 36(1):84. PubMed ID: 28645305
[TBL] [Abstract][Full Text] [Related]
13. Expression of BAG-1 is closely related to cell differentiation and TNM stage in esophageal cancer and its downregulation inhibits the proliferation and invasion of human esophageal carcinoma cells.
Huang B; Zhou H; Lang X; Liu Z; Xiong F; Wang S
Oncol Rep; 2014 Oct; 32(4):1441-6. PubMed ID: 25069471
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of long noncoding RNA MALAT1 contributes to proliferation and metastasis in esophageal squamous cell carcinoma.
Hu L; Wu Y; Tan D; Meng H; Wang K; Bai Y; Yang K
J Exp Clin Cancer Res; 2015 Jan; 34(1):7. PubMed ID: 25613496
[TBL] [Abstract][Full Text] [Related]
15. Tex10 promotes stemness and EMT phenotypes in esophageal squamous cell carcinoma via the Wnt/β‑catenin pathway.
Xiang X; Xiong R; Yu C; Deng L; Bie J; Xiao D; Chen Z; Zhou Y; Li X; Liu K; Feng G
Oncol Rep; 2019 Dec; 42(6):2600-2610. PubMed ID: 31638260
[TBL] [Abstract][Full Text] [Related]
16. RFT2 is overexpressed in esophageal squamous cell carcinoma and promotes tumorigenesis by sustaining cell proliferation and protecting against cell death.
Jiang XR; Yu XY; Fan JH; Guo L; Zhu C; Jiang W; Lu SH
Cancer Lett; 2014 Oct; 353(1):78-86. PubMed ID: 25045844
[TBL] [Abstract][Full Text] [Related]
17. C-terminal binding protein‑2 mediates cisplatin chemoresistance in esophageal cancer cells via the inhibition of apoptosis.
Shi H; Mao Y; Ju Q; Wu Y; Bai W; Wang P; Zhang Y; Jiang M
Int J Oncol; 2018 Jul; 53(1):167-176. PubMed ID: 29658564
[TBL] [Abstract][Full Text] [Related]
18. DCLK1 inhibition attenuates tumorigenesis and improves chemosensitivity in esophageal squamous cell carcinoma by inhibiting β-catenin/c-Myc signaling.
Zhang L; Zhou S; Guo E; Chen X; Yang J; Li X
Pflugers Arch; 2020 Aug; 472(8):1041-1049. PubMed ID: 32533239
[TBL] [Abstract][Full Text] [Related]
19. CtBP2 contributes to malignant development of human esophageal squamous cell carcinoma by regulation of p16INK4A.
Guan C; Shi H; Wang H; Zhang J; Ni W; Chen B; Hou S; Yang X; Shen A; Ni R
J Cell Biochem; 2013 Jun; 114(6):1343-54. PubMed ID: 23255392
[TBL] [Abstract][Full Text] [Related]
20. BMI-1 suppression increases the radiosensitivity of oesophageal carcinoma via the PI3K/Akt signaling pathway.
Yang XX; Ma M; Sang MX; Zhang XY; Liu ZK; Song H; Zhu SC
Oncol Rep; 2018 Feb; 39(2):667-678. PubMed ID: 29207170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]